Multiple positive drug tests have netted UFC lightweight Alex Gorgees a 16-month suspension.
UFC anti-doping partner U.S. Anti-Doping Agency announced Gorgees accepted the punishment after failing three tests beginning with an in-competition sample for UFC Fight Night 142 this past December.
Per USADA, Gorgees came up positive on Dec. 2, 2018, for a metabolite of the steroid drostanolone and the M3 metabolite of dehydrochlormethyltestosterone (DHCMT), which came to prominence with Jon Jones’ second USADA violation. Drostanolone and DHCMT are non-specified substances in the class of Anabolic Agents and prohibited at all times under the UFC’s anti-doping policy.
Like Jones, Gorgees continued to pop positive for the long-term M3 metabolite on December 10 and January 16. He also agreed to cooperate with USADA, providing “detailed evidence of his use of prohibited substances before entering the UFC anti-doping program.” He continued to cooperate even after his release from the UFC, USADA stated.
Gorgees, 23, faced a two-year suspension for his first anti-doping offense, but received an eight-month reduction in exchange for his honesty. His suspension is retroactive to December 2, 2018.
A product of Australian Top Team, Gorgees (7-1 MMA, 0-1 UFC) made his lone octagon appearance at UFC Fight Night 142, losing a decision to Damir Ismagulov. It was his first loss as professional.
For more on the UFC’s upcoming schedule, check out the UFC Rumors section of the site.
